Inventor · disambiguated record
Mark Edward Schnute
Also filed as: SCHNUTE MARK E · SCHNUTE MARK EDWARD
26 granted patents·19 pending applications·237 citations·filing 1998–2023
95Inventor score
Top patents by PatentIndex Score
45 records- 0191US6248739B1Quinolinecarboxamides as antiviral agentsUPJOHN CO·Filed 1999·Granted Jun 19, 2001·59 cites·81 claims
- 0290US11708360B2N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitorsPFIZER·Filed 2021·Granted Jul 25, 2023·2 cites·16 claims
- 0388US10975065B2N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitorsPFIZER·Filed 2019·Granted Apr 13, 2021·3 cites·14 claims
- 0488US6559145B2Heterocycle carboxamides as antiviral agentsUPJOHN CO·Filed 2001·Granted May 6, 2003·29 cites·25 claims
- 0586US6730682B2Heterocycle carboxamides as antiviral agentsUPJOHN CO·Filed 2001·Granted May 4, 2004·23 cites·15 claims
- 0685US6624159B2Heterocycle carboxamides as antiviral agentsUPJOHN CO·Filed 2001·Granted Sep 23, 2003·26 cites·46 claims
- 0783US9920054B2Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereofPFIZER·Filed 2017·Granted Mar 20, 2018·2 cites·5 claims
- 0883US9670201B2Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereofPFIZER·Filed 2015·Granted Jun 6, 2017·3 cites·14 claims
- 0983US6239142B14-oxo-4,7-dihydro-thieno[2,3-b]pyridine-5carboxamides as antiviral agentsUPJOHN CO·Filed 2000·Granted May 29, 2001·22 cites·36 claims
- 1082US10426135B2Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereofPFIZER·Filed 2019·Granted Oct 1, 2019·2 cites·7 claims
- 1181US10266513B2Bruton's tyrosine kinase inhibitorsPFIZER·Filed 2017·Granted Apr 23, 2019·2 cites·6 claims
- 1280US12312344B2N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitorsPFIZER·Filed 2023·Granted May 27, 2025·0 cites·20 claims
- 1379US6852731B2Antiviral compoundsPFIZER·Filed 2003·Granted Feb 8, 2005·15 cites·64 claims
- 1477US10227346B2Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use therofPFIZER·Filed 2018·Granted Mar 12, 2019·1 cites·4 claims
- 1571US6093732A4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agentsUPJOHN CO·Filed 1998·Granted Jul 25, 2000·17 cites·17 claims
- 1670US10385036B2Sulfonamide-substituted indole modulators of RORC2 and methods of use thereofPFIZER·Filed 2016·Granted Aug 20, 2019·1 cites·13 claims
- 1770US6653307B21-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agentsUPJOHN CO·Filed 2001·Granted Nov 25, 2003·4 cites·32 claims
- 1868US10336748B2Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereofPFIZER·Filed 2016·Granted Jul 2, 2019·1 cites·11 claims
- 1968US2021002251A1Bruton's Tyrosine Kinase InhibitorsPFIZER·Filed 2020·Application pending·0 cites
- 2067US6248736B14-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agentsUPJOHN CO·Filed 1999·Granted Jun 19, 2001·22 cites·17 claims
- 2167US2020039960A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2019·Application pending·0 cites
- 2266US10815213B2Bruton's tyrosine kinase inhibitorsPFIZER·Filed 2019·Granted Oct 27, 2020·0 cites·4 claims
- 2365US2019144429A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2019·Application pending·0 cites
- 2465US2019387710A1Methyl- and Trifluromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use ThereofPFIZER·Filed 2019·Application pending·0 cites
- 2563US2016046597A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2014·Application pending·0 cites
- 2663US2018282304A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2018·Application pending·0 cites
- 2762US6562822B2Heterocyle carboxamides as antiviral agentsUPJOHN CO·Filed 2001·Granted May 13, 2003·2 cites·21 claims
- 2862US2018086736A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2017·Application pending·0 cites
- 2962US2025367129A1Lipid Compounds and Uses ThereofPFIZER·Filed 2023·Application pending·0 cites
- 3060US2017233371A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2017·Application pending·0 cites
- 3159US2015291554A1Bruton's Tyrosine Kinase InhibitorsPFIZER·Filed 2013·Application pending·0 cites
- 3258US6831081B24-Oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agentsPHARMACIA & UPJOHN·Filed 2003·Granted Dec 14, 2004·1 cites·55 claims
- 3355US11655252B2Aminopyrimidinyl derivativesPFIZER·Filed 2021·Granted May 23, 2023·0 cites·20 claims
- 3452US6903097B2Heterocycle carboxamides as antiviral agentsUPJOHN CO·Filed 2002·Granted Jun 7, 2005·0 cites·27 claims
- 3552US2004180910A1Heterocycle carboxamides as antiviral agentsFiled 2004·Application pending·0 cites
- 3651US2004142928A1Heterocycle carboxamides as antiviral agentsFiled 2003·Application pending·0 cites
- 3750US2004024209A11-Aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agentsFiled 2003·Application pending·0 cites
- 3848US2004029879A1Heterocycle carboxamides as antiviral agentsFiled 2003·Application pending·0 cites
- 3946US2011009435A1Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositionsPFIZER·Filed 2008·Application pending·0 cites
- 4044US2005004161A14-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agentsAGOURON PHARMA·Filed 2004·Application pending·0 cites
- 4143US6861438B2Antiviral agentsPFIZER·Filed 2003·Granted Mar 1, 2005·0 cites·50 claims
- 4243US2004116464A1Aryl-ethanolamine derivatives as antiviral agentsFiled 2003·Application pending·0 cites
- 4341US6878705B24-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agentsPFIZER·Filed 2003·Granted Apr 12, 2005·0 cites·83 claims
- 4441US2005049245A1Heteroaryl-ethanolamine derivatives as antiviral agentsFiled 2003·Application pending·0 cites
- 4539US2004110787A1Heteroaryl-ethanolamine derivatives as antiviral agentsFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Edward Schnute files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →